<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="1" ids="16247">Phospholipids</z:chebi> bearing a proportion of anionic species such as phosphatidylserine are necessary to promote the <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> potential of the protein C pathway </plain></SENT>
<SENT sid="1" pm="."><plain>Factor Xa (200 or 350 pM) was found to activate protein C in a thrombomodulin-independent reaction requiring only <z:chebi fb="1" ids="16247">phospholipids</z:chebi> in Al(OH)3,-adsorbed plasma resupplemented with physiological concentrations of protein C (70 nM) and protein S (130 nM) </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> experiments were performed in the presence of an excess of hirudin </plain></SENT>
<SENT sid="3" pm="."><plain>The activity of activated protein C was assessed by the survival of factor Va </plain></SENT>
<SENT sid="4" pm="."><plain>The optimal <z:chebi fb="0" ids="16247">phospholipid</z:chebi> concentration range was 5 to 25 microM with a proportion of phosphatidylserine of 50% (mol/mol) resulting in a half-life of factor Va of 7.5 min in the absence of protein S and 4.2 min in its presence </plain></SENT>
<SENT sid="5" pm="."><plain>Dns-EGR-Xa, an inactive derivative of factor Xa, behaved as an apparent protector of factor Va </plain></SENT>
<SENT sid="6" pm="."><plain>When replacing factor Xa, thrombin at 10 nM was not an efficient protein C activator in the absence of purified human placenta thrombomodulin </plain></SENT>
<SENT sid="7" pm="."><plain>In the presence of 100 pM activated protein C, factor Va half-life was 2 min in the absence of protein S and 1.1 min in its presence in the above optimal <z:chebi fb="0" ids="16247">phospholipid</z:chebi> concentration range </plain></SENT>
<SENT sid="8" pm="."><plain>The presence of protein S allowed reduction of <z:chebi fb="0" ids="16247">phospholipid</z:chebi> requirements </plain></SENT>
<SENT sid="9" pm="."><plain>Annexin-V (placental <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> protein-I), a potent <z:chebi fb="0" ids="16247">phospholipid</z:chebi> <z:chebi fb="68" ids="48706">antagonist</z:chebi>, fully protected factor Va from degradation by <z:chebi fb="0" ids="16247">phospholipid</z:chebi>-dependent mechanisms </plain></SENT>
<SENT sid="10" pm="."><plain>Factor Va was partially protected in the plasma of a patient having experienced <z:mp ids='MP_0005048'>thrombosis</z:mp> associated with <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e>-like <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> and anti-<z:chebi fb="0" ids="16247">phospholipid</z:chebi> auto-antibodies.(ABSTRACT TRUNCATED AT 250 WORDS) </plain></SENT>
</text></document>